Monoclonal Antibodies Targeting IL-5/IL-5R May Benefit Certain Patients With COPD

Chronic obstructive pulmonary disease (COPD) exacerbations and oral corticosteroid use dropped in patients treated with monoclonal antibodies targeting interleukin (IL)-5 and its receptor (IL-5R), a study found.

Related Keywords

,International Journal Of Chronic Obstructive Pulmonary Disease ,International Journal ,Chronic Obstructive Pulmonary Disease ,Copd ,Docs ,Il5 ,Il5r ,Exacerbations ,